Jazz Pharmaceuticals plc buy UBS Group AG
Start price
07.03.25
/
50%
€129.25
Target price
07.03.26
€164.98
Performance (%)
8.70%
Price
17.12.25
€140.50
Summary
This prediction is currently active. With a performance of 8.70%, the BUY prediction by UBS_Group_AG for Jazz Pharmaceuticals plc is trending in the right direction. This prediction currently runs until 07.03.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Jazz Pharmaceuticals plc | -0.390% | -0.390% |
| iShares Core DAX® | -1.212% | 1.925% |
| iShares Nasdaq 100 | -4.714% | -1.810% |
| iShares Nikkei 225® | -2.976% | -2.660% |
| iShares S&P 500 | -2.744% | -0.448% |
Comments by UBS_Group_AG for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $179.00 price target on the stock, up previously from $145.00.
Ratings data for JAZZ provided by MarketBeat